Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
shingles vaccine
Pharma
FDA blocks publication of vaccine safety studies: NYT
The FDA-conducted studies reportedly found COVID vaccines and GSK's shingles vaccine Shringrix safe and effective, according to The New York Times.
Zoey Becker
May 6, 2026 11:20am
AstraZeneca-Alteogen, Taiho, WuXi—Fierce Pharma Asia
Mar 21, 2025 9:10am
Merck washes hands of 1,000-plus Zostavax lawsuits
Jul 8, 2024 10:28am
GSK partners up with Zhifei to market Shingrix in China
Oct 9, 2023 11:20am
GSK's Shingrix aces phase 4 trial in China with 100% efficacy
Aug 23, 2023 10:14am
Pfizer, Gilead, GSK to dominate infectious disease market
Jul 20, 2023 9:45am
